Universal Influenza A Vaccine in Healthy Adults
All edits
Edits on 14 Jan, 2024
Golden AI
Edits made to:
Infobox (+15 properties)
Article (+328 characters)
Universal Influenza A Vaccine in Healthy Adults
Article
Study summary
The goal of this Phase 1, single- center, randomized, double blind, placebo-controlled dose-escalation study is to evaluate the safety, tolerability and immunogenicity of UFluA vaccine candidate at two dose levels and two schedules in healthy adult (18-45-year-old, inclusive) male and non-pregnant female subjects.
Infobox
Is a
NCT Number
Trial Recruitment Size
270
Trial Sponsor
Clinical Trial Start Date
December 1, 2021
0Primary Completion Date
October 10, 2023
0Study Completion Date
October 10, 2023
0Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Prevention0
Official Website
Official Name
A Phase 1, Randomized, Double-Blind, Placebo-Controlled Dose-Escalation Study Evaluating Safety and Immunogenicity of Influenza A Hemagglutinin Stabilized Stem Nanoparticle Vaccine Candidate in Healthy Adults0
Last Updated
December 13, 2023
0Allocation Type
Randomized0
Intervention Model
Parallel Assignment0
Masking Type
Double0
Find more entities like Universal Influenza A Vaccine in Healthy Adults
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.